先看重点
在8,238名45岁及以上中国成年人中,抑郁症状与肌少症的比值比较高(OR 1.30,95%CI 1.03-1.63),日常生活活动(ADL)障碍解释了其中20.00%的关联。这是按关联进行分析的调查数据,不能证明抑郁会导致肌肉流失。
证据类型
队列研究
解读依据
公开摘要
阅读重点
关联与混杂
研究在问什么
抑郁和肌少症(肌肉量与功能下降)在中国中老年人中都很常见,但二者如何联系并不清楚。作者检验了日常活动困难是否位于抑郁症状与肌少症之间的路径上。
研究了谁,如何研究
分析中国健康与养老追踪调查(CHARLS)数据,纳入8,238名45岁及以上参与者(男性3,358人,女性4,880人)。用流行病学研究中心抑郁量表评估抑郁症状;用logistic回归检验抑郁症状、ADL障碍与肌少症的关系,并校正社会活动、慢性病、人口学因素和生活方式;再用中介分析估计抑郁与肌少症的关联有多少经由ADL障碍。摘要未说明肌少症的判定标准。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1抑郁症状与肌少症的比值比较高(OR 1.30,95%CI 1.03-1.63,P=0.0269)。
- 2ADL障碍与肌少症的关联更强(OR 1.94,95%CI 1.37-2.75,P<0.001)。
- 3ADL障碍部分介导了抑郁与肌少症的关联:估计间接效应为0.006(95%CI 0.003,0.008),中介比例为20.00%。
局限与不确定性
- 1抑郁与肌少症的测量似乎来自同一时间点,无法确定关联的方向和中介的先后顺序;也可能是肌肉流失在先、抑郁在后。
- 2中介比例为20.00%,意味着大部分关联并未由ADL障碍解释;抑郁的比值比区间也较宽(1.03-1.63)。
- 3摘要提出的心理支持加肌力训练的建议超出了这项分析所检验的内容;作者自己也呼吁开展纵向研究。
- 4本解读仅基于摘要。
对日常健康的启示
在中国中老年人中,情绪低落、日常活动困难和肌肉量偏低常常同时出现,因此其中任何一项都可以提醒你留意其他两项。这并不说明治疗抑郁就能预防肌少症;对情绪或力量的担忧应与临床医生沟通。
如何联系自己的数据
握力测试不属于常见的可穿戴数据,但手表记录的每日步数、步行速度和活动量可以反映日常活动能力是否在下降。请用同一设备持续数周记录,关注持续的下滑,而不是某一天的低值。
如何理解这类证据
暴露先于随访结局,仍可能存在混杂和反向因果。危险比不是个人绝对风险,也不等于已证明的干预效果。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Depressive symptoms and sarcopenia, often observed among middle-aged and elderly individuals, are significant health concerns in China, particularly given the country's rapidly aging population. Depressive symptoms, characterized by persistent feelings of sadness and loss of interest, can significantly impact quality of life. Little is known about the underlying pathway connecting these two conditions.
Methods
The data for this study were derived from the China Health and Retirement Longitudinal Study (CHARLS). Depressive symptoms were evaluated using the Centre for Epidemiological Studies Depression (CSED) scale. Logistic regression analyses were employed to investigate the association between depressive symptoms, activities of daily living (ADL) disability, and sarcopenia, while adjusting for potential confounding factors. The selection of predictor variables, including social activity, chronic diseases, demographic factors, and lifestyle habits, was based on their known associations with mental health, physical functioning and sarcopenia. These variables were included to ensure a comprehensive adjustment for potential confounding factors and to provide a more accurate estimation of the relationship between depressive symptoms and sarcopenia. Additionally, mediation analysis was conducted to assess the mediating role of ADL disability in the relationship between depressive symptoms and sarcopenia.
Results
A comprehensive study was conducted on a total of 8,238 participants aged 45 years and older, comprising 3,358 men and 4,880 women. Logistic regression analyses were conducted to identify significant associations between depressive symptoms (OR = 1.30, P = 0.0269,95%CI = 1.03-1.63), ADL disability (OR = 1.94, P < 0.001,95%CI = 1.37-2.75) and sarcopenia. The results revealed significant relationships among these variables. Furthermore, mediation effect analyses demonstrated that ADL disability partially mediated the association between depressive symptoms and sarcopenia (estimated indirect effect: 0.006, 95% CI: 0.003, 0.008, proportion of mediation effect: 20.00%).
Conclusions
The study underscores a significant association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China, with ADL disability acting as a mediator. These findings offer novel insights for targeted health interventions. Future interventions should effectively combat sarcopenia by integrating psychological support with muscle-strengthening exercise programs. By addressing both depressive symptoms and ADL disability, clinicians and public health professionals can enhance outcomes for this demographic. Collaborative efforts across disciplines are essential for providing comprehensive health management tailored to the needs of middle-aged and elderly individuals. Future research should longitudinally assess the impact of such integrated interventions on sarcopenia prevention and depressive symptom alleviation. Additionally, investigating the role of social and environmental factors in mediating this relationship is crucial for developing more effective health strategies for this vulnerable population.
来源与署名
Association between depressive symptoms and sarcopenia among middle-aged and elderly individuals in China: the mediation effect of activities of daily living (ADL) disability.
Li Q, Cen W, Yang T, Tao S.
BMC psychiatry · 2024-06-10
DOI: 10.1186/s12888-024-05885-y ↗PubMed · 38858698 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
ACSM综述137项系统评价:抗阻训练有效,影响结果的方案细节很少
美国运动医学会汇总了137项系统评价(超过30,000名健康成年人),认为抗阻训练在力量、肌肉量、爆发力、耐力和多项功能测试上优于不运动。能一致影响结果的方案细节很少:较大负荷(不低于单次最大重复量的80%)和2至3组有利于力量,每周至少10组有利于肌肉量,而训练至力竭、器械类型和周期化则没有一致影响。它汇总的是系统评价而非新试验,没有合并效应量,所依据的多为未经训练者,且各评价所含的原始试验有重叠。
Medicine & Science in Sports & Exercise
几乎所有抗阻训练方案都优于不运动,大负荷在力量上排名居前
一项纳入随机试验的网状荟萃分析(力量网络178项研究、5097人,肌肥大网络119项研究、3364人)显示,几乎所有抗阻训练方案都优于不运动。大负荷、多组、每周至少3次的方案在力量上排名最前(标准化均数差1.60,95%可信区间1.38至1.82),大负荷、多组、每周2次的方案在肌肥大上排名最前(0.66,0.47至0.85)。多数方案之间在统计学上无法区分(91%的两两比较中95%可信区间包含零),且偏倚风险为中到高,因此排名只是初步参考。
British Journal of Sports Medicine
肌肉强化活动与更低的死亡、心血管病、癌症和糖尿病风险相关
汇总16项成年人前瞻性队列研究,进行肌肉强化活动者的全因死亡风险低15%(RR 0.85,95%置信区间0.79至0.93),心血管疾病和糖尿病风险各低17%(RR均为0.83)。全因死亡曲线在每周约40分钟时最低(RR 0.83),但更大运动量是有益还是有害尚不清楚。这些都是观察性结果,主要来自美国的自我报告数据,作者将大多数结局的证据确定性评为极低。
British Journal of Sports Medicine
蛋白补充剂配合力量训练:额外增益有限,年长者更少
汇总49项随机对照试验、1863名进行至少6周抗阻训练的健康成年人,蛋白补充剂在单纯训练的基础上使去脂体重多增加0.30 kg(95%置信区间0.09至0.52),使最大重复量力量多增加2.49 kg(0.64至4.33)。这些增量远小于训练本身的作用,年龄越大越弱,而所谓1.6 g/kg/天的平台点没有统计学意义(P=0.079)。有一位作者曾获美国国家乳制品委员会资助,该机构也资助过纳入分析的试验。
British Journal of Sports Medicine

